Cargando…
Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response
Vaccines have been used to prevent and eradicate different diseases for over 200 years, and new vaccine technologies have the potential to prevent many common illnesses. Cancer, despite many advances in therapeutics, is still the second leading causes of death in the United States. Prophylactic, or...
Autores principales: | Crews, Davis W., Dombroski, Jenna A., King, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044825/ https://www.ncbi.nlm.nih.gov/pubmed/33869008 http://dx.doi.org/10.3389/fonc.2021.626463 |
Ejemplares similares
-
Engineering of Exosomes to Target Cancer Metastasis
por: Zhang, Zhenjiang, et al.
Publicado: (2019) -
Fast DNA Vaccination Strategy Elicits a Stronger Immune Response Dependent on CD8(+)CD11c(+) Cell Accumulation
por: Liu, Chenlu, et al.
Publicado: (2021) -
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential
por: Lohmueller, Jason J., et al.
Publicado: (2016) -
Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study
por: Hernandez Puente, Cinthia Violeta, et al.
Publicado: (2020) -
Control of the Adaptive Immune Response by Tumor Vasculature
por: Mauge, Laetitia, et al.
Publicado: (2014)